Literature DB >> 28966995

Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in Sickle Cell Disease.

Maritza A Jimenez1,2, Enrico Novelli1,3, Gray D Shaw4, Prithu Sundd1,2,5.   

Abstract

Entities:  

Year:  2017        PMID： 28966995      PMCID： PMC5617353          DOI： 10.1182/bloodadvances.2017006742

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  20 in total

Review 1.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Quantitative microfluidic fluorescence microscopy to study vaso-occlusion in sickle cell disease.

Authors:  Maritza A Jimenez; Egemen Tutuncuoglu; Suchitra Barge; Enrico M Novelli; Prithu Sundd
Journal:  Haematologica       Date:  2015-05-14       Impact factor: 9.941

3.  Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia.

Authors:  Venina M Dominical; Leigh Samsel; James S Nichols; Fernando F Costa; J Phillip McCoy; Nicola Conran; Gregory J Kato
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

4.  Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.

Authors:  Margaret F Bennewitz; Maritza A Jimenez; Ravi Vats; Egemen Tutuncuoglu; Jude Jonassaint; Gregory J Kato; Mark T Gladwin; Prithu Sundd
Journal:  JCI Insight       Date:  2017-01-12

Review 5.  Sickle-cell disease.

Authors:  David C Rees; Thomas N Williams; Mark T Gladwin
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

6.  Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.

Authors:  Susan Adam Benard; Thomas M Smith; Kristina Cunningham; Jaison Jacob; Thamara DeSilva; Laura Lin; Gray D Shaw; Ron Kriz; Kerry S Kelleher
Journal:  Biochemistry       Date:  2008-03-26       Impact factor: 3.162

7.  Glycoprotein Ibalpha inhibitor complex structure reveals a combined steric and allosteric mechanism of von Willebrand factor antagonism.

Authors:  Paul A McEwan; Robert K Andrews; Jonas Emsley
Journal:  Blood       Date:  2009-09-02       Impact factor: 22.113

8.  Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation.

Authors:  Jing Li; Kyungho Kim; Eunsil Hahm; Robert Molokie; Nissim Hay; Victor R Gordeuk; Xiaoping Du; Jaehyung Cho
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

10.  Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D I Simon; Z Chen; H Xu; C Q Li; J f Dong; L V McIntire; C M Ballantyne; L Zhang; M I Furman; M C Berndt; J A López
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307
View more
  10 in total

Review 1.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

2.  Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.

Authors:  Jing Li; Kyungho Kim; Si-Yeon Jeong; Joyce Chiu; Bei Xiong; Pavel A Petukhov; Xiangrong Dai; Xiaoyi Li; Robert K Andrews; Xiaoping Du; Philip J Hogg; Jaehyung Cho
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

3.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2019-10-31       Impact factor: 9.941

4.  Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Authors:  Sivasami Pulavendran; Jennifer M Rudd; Prasanthi Maram; Paul G Thomas; Ramachandran Akhilesh; Jerry R Malayer; Vincent T K Chow; Narasaraju Teluguakula
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

5.  Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Authors:  Erdem Kucukal; Anton Ilich; Nigel S Key; Jane A Little; Umut A Gurkan
Journal:  Am J Hematol       Date:  2018-06-15       Impact factor: 10.047

6.  Redox Signaling in Sickle Cell Disease.

Authors:  Deirdre Nolfi-Donegan; Tirthadipa Pradhan-Sundd; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Curr Opin Physiol       Date:  2019-05-02

Review 7.  Innate immune cells, major protagonists of sickle cell disease pathophysiology.

Authors:  Slimane Allali; Thiago Trovati Maciel; Olivier Hermine; Mariane de Montalembert
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

8.  Platelet Extracellular Vesicles Drive Inflammasome-IL-1β-Dependent Lung Injury in Sickle Cell Disease.

Authors:  Ravi Vats; Tomasz Brzoska; Margaret F Bennewitz; Maritza A Jimenez; Tirthadipa Pradhan-Sundd; Egemen Tutuncuoglu; Jude Jonassaint; Edgar Gutierrez; Simon C Watkins; Sruti Shiva; Melanie J Scott; Adrian E Morelli; Matthew D Neal; Gregory J Kato; Mark T Gladwin; Prithu Sundd
Journal:  Am J Respir Crit Care Med       Date:  2020-01-01       Impact factor: 21.405

9.  Model-dependent contributions of FXII and FXI to venous thrombosis in mice.

Authors:  Steven P Grover; Tatianna M Olson; Brian C Cooley; Nigel Mackman
Journal:  J Thromb Haemost       Date:  2020-08-28       Impact factor: 5.824

10.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.